Research objective integrated omics research in understanding pituitary adenomas pituitary adenomas (pas) are considered one of the most frequent intracranial tumours, having salient impacts on humans, resulting in comorbidities such as hypertension, cardiac arrhythmias, cardiac failure, insulin resistance, diabetes, mass effect, and arthritis, along with several other metabolic disorders, etc. one of the major challenges in pas classification (who 2017) was that only transcription factors, the type of cell they originated from, and the hormones they secreted were considered; further, no imaging and omics technology were utilized to understand these pas better. this led to the burdensome diagnosis, as individuals were unable to know if they might have generated this tumour until they showed the symptoms of comorbidities. hormonal imbalance was observed in these individuals, leading to over secretion or deficiency of certain hormones and resulting in endocrinological malfunction such as acromegaly disorder (excessive growth hormones causing gigantism), and cushing's syndrome (caused by excessive secretion of adrenocorticoids). both acromegaly and cushing's were considered as functional pituitary adenomas (fpas), leading to osteoporosis, hypertension, type 2 diabetes, vision loss, sexual dysfunctions, and high mortality due to secondary clinical complications. nonfunctional pituitary adenomas (nfpas) are non-secreting but remain undetected until they grow into giant pituitary tumors, leading to mass effect and vision loss, resulting in neurological deficits. nasopharyngeal surgery is preferred as the potential clinical treatment strategy, but only 70% of tumor tissue is removed, and the remaining 30% of tumors show high recurrence. surgery followed by normal radiation therapy is not recommended in pas as in the case of other cancer types because it potentially disrupts the functioning of the normal pituitary master gland. thus, long-term monitoring is required for the patients to assess tumor growth, hormone levels, and potential recurrence. pas significantly impact a patient's physical, emotional, social well-being, and overall quality of life.